Patients with a heterozygous mutation of CCM3 have a high susceptibility to develop cerebral cavernous malformations, and it has been shown recently that they can also develop meningiomas, which places CCM3 as a possible tumor suppressor gene (Clark et al., 2013; Riant et al., 2013). This evidence concerns the gene PDCD10 and cerebral cavernous malformation.